Tranexamic acid

Generic Name
Tranexamic acid
Brand Names
Cyklokapron, Lysteda
Drug Type
Small Molecule
Chemical Formula
C8H15NO2
CAS Number
1197-18-8
Unique Ingredient Identifier
6T84R30KC1
Background

Tranexamic acid is a synthetic derivative of lysine used as an antifibrinolytic in the treatment and prevention of major bleeding. It possesses a similar mechanism of action to aminocaproic acid but is approximately 10-fold more potent.

It was first patented in 1957 and received its initial US approval in 1986.

Indication

Taken orally, tranexamic acid is indicated for the treatment of hereditary angioedema, cyclic heavy menstrual bleeding in premenopausal females, and other instances of significant bleeding in the context of hyperfibrinolysis. Given intravenously, tranexamic acid is indicated for short-term use (2-8 days) in patients with hemophilia to prevent or reduce bleed...

Associated Conditions
Bleeding, Heavy Menstrual Bleeding, Hereditary Angioedema (HAE)
Associated Therapies
-

Tranexamic Acid and Pediatric Adenotonsillectomy

First Posted Date
2010-10-26
Last Posted Date
2010-12-22
Lead Sponsor
Irmandade Santa Casa de Misericórdia de Porto Alegre
Target Recruit Count
95
Registration Number
NCT01228136
Locations
🇧🇷

Hospital da Criança Santo Antônio, Porto Alegre, Rio Grande do Sul, Brazil

Tranexamic Acid in Dacryocystorhinostomy

First Posted Date
2010-10-15
Last Posted Date
2010-10-15
Lead Sponsor
HaEmek Medical Center, Israel
Target Recruit Count
80
Registration Number
NCT01221909
Locations
🇮🇱

Dept. of Ophthalmology, HaEmek medical center, Afula, Israel

Dose-ranging Study of Tranexamic Acid in Valve Surgery

Not Applicable
Completed
Conditions
Interventions
First Posted Date
2010-08-31
Last Posted Date
2012-11-06
Lead Sponsor
Chinese Academy of Medical Sciences, Fuwai Hospital
Target Recruit Count
175
Registration Number
NCT01191554
Locations
🇨🇳

Cardiovascular Institute and Fuwai Hospital, Beijing, China

Lysteda Pediatric Research Equity Act (PREA) Pharmacokinetic Study in Adolescent Females With Heavy Menstrual Bleeding

Phase 4
Completed
Conditions
Interventions
First Posted Date
2010-08-27
Last Posted Date
2012-07-16
Lead Sponsor
Ferring Pharmaceuticals
Target Recruit Count
20
Registration Number
NCT01190150
Locations
🇺🇸

West Coast Clinical Trials, Cypress, California, United States

Tranexamic Acid (TXA) in Pediatric Cardiac Surgery

Phase 2
Completed
Conditions
Interventions
First Posted Date
2010-06-10
Last Posted Date
2014-07-23
Lead Sponsor
Centre Chirurgical Marie Lannelongue
Target Recruit Count
18
Registration Number
NCT01141127
Locations
🇫🇷

Centre Chirurgical Marie Lannelongue, Plessis-Robinson, France

Multicenter, Randomized Placebo-controlled Clinical Trial to Evaluate the Effect of Perioperative Use of Tranexamic Acid on Transfusion Requirements and Surgical Bleeding in Major Spine Surgery

First Posted Date
2010-06-03
Last Posted Date
2015-02-24
Lead Sponsor
Hospital Universitari Vall d'Hebron Research Institute
Target Recruit Count
96
Registration Number
NCT01136590
Locations
🇪🇸

Hospital Vall d'Hebron de Barcelona, Barcelona, Spain

🇪🇸

Hospital de Getafe, Getafe, Madrid, Spain

🇪🇸

Hospital de Bellvitge, Hospitalet de Llobregat, Barcelona, Spain

and more 1 locations

Intravenous Tranexamic Acid and Intraoperative Visualization During Functional Endoscopic Sinus Surgery

First Posted Date
2010-04-27
Last Posted Date
2012-04-27
Lead Sponsor
University of Alberta
Target Recruit Count
28
Registration Number
NCT01111669
Locations
🇨🇦

University of Alberta Hospital, Royal Alexandra Hospital, Edmonton, Alberta, Canada

Blood Loss and Transfusion Requirement in Infants Treated With Tranexamic Acid

Phase 3
Suspended
Conditions
Interventions
First Posted Date
2010-03-29
Last Posted Date
2019-07-15
Lead Sponsor
The Hospital for Sick Children
Target Recruit Count
90
Registration Number
NCT01094977
Locations
🇨🇦

The Hospital for Sick Children, Toronto, Ontario, Canada

The Effect of Tranexamic Acid on Postpartum Hemorrhage During and After Cesarean Delivery

Phase 1
Completed
Conditions
Interventions
First Posted Date
2010-03-11
Last Posted Date
2011-01-25
Lead Sponsor
Tehran University of Medical Sciences
Target Recruit Count
100
Registration Number
NCT01085006
Locations
🇮🇷

Laleh Eslamian, Tehran, Iran, Islamic Republic of

The Effect of Tranexamic Acid on Postoperative Blood Loss and Coagulation in Patients With Preoperative Anemia Undergoing Off-Pump Coronary Artery Bypass Graft; Double Blind Randomized Control Study

Phase 4
Completed
Conditions
Interventions
First Posted Date
2010-02-11
Last Posted Date
2010-12-06
Lead Sponsor
Yonsei University
Target Recruit Count
90
Registration Number
NCT01067638
Locations
🇰🇷

Yonsei Univ., Seoul, Korea, Republic of

© Copyright 2024. All Rights Reserved by MedPath